Acute lymphoblastic leukemia in adults.

Bayard D. Clarkson(Memorial Sloan Kettering Cancer Center), R. S. K. Chaganti(Leukemia and Lymphoma Society), Toby Gee(Leukemia and Lymphoma Society), Sanford Kempin(Leukemia and Lymphoma Society), Michael Andreeff(The University of Texas MD Anderson Cancer Center), Benjamín Koziner(Leukemia and Lymphoma Society), Zalmen A. Arlin(Leukemia and Lymphoma Society), Claudia Little(Leukemia and Lymphoma Society), Roland Mertelsmann(Unknown), Stephen B. Ellis(Leukemia and Lymphoma Society)
PubMed
June 1, 1985
Cited by 188

Related Papers

Mutations Involving the Transcription Factor CBFA1 Cause Cleidocranial Dysplasia
|Cell|1997|1.5k
Recombinant Human Granulocyte Colony-Stimulating Factor: Effects on Normal and Leukemic Myeloid Cells
|Science|1986|1.2k
Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60)
|The Lancet Oncology|2008|1.1k
Early Results of a Chemoimmunotherapy Regimen of Fludarabine, Cyclophosphamide, and Rituximab As Initial Therapy for Chronic Lymphocytic Leukemia
|Journal of Clinical Oncology|2005|951
Crystal structures of the kinase domain of c-Abl in complex with the small molecule inhibitors PD173955 and imatinib (STI-571).
|PubMed|2002|941